Volume 12, Issue 4 (Jul-Aug 2018)                   mljgoums 2018, 12(4): 12-16 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Gray Z, Douzandegan Y, Tabarraei A, Moradi A. Optimization of SW480 Colon Cancer Cells Transfection with Lipofectamine 2000. mljgoums. 2018; 12 (4) :12-16
URL: http://mlj.goums.ac.ir/article-1-1088-en.html
1- Department of Microbiology, school of medicine, Golestan University of medical science, Gorgan, Iran
2- Golestan research center of Gastroenterology and Hepatology, Department of Microbiology, school of medicine, Golestan University of medical science, Gorgan, Iran , abmoradi@gmail.com
Abstract:   (5817 Views)
          Background and Objectives: Nonviral carriers including those based on synthetic cationic lipids, offer several advantages over the viral counterparts. These carriers are able to form complexes with nucleic acids and deliver genes into the cells via the cellular endocytosis pathway, without significant toxicity. The level of transgenes expression depends on some experimental variables including cell type and density, Lipofectamine and DNA concentrations and Lipofectamine-DNA complexing time. The main objective of this study was to optimize transfection of SW480 colon cancer cells with Lipofectamine 2000.
          Methods: In this study, SW480 cells were transfected with plasmid containing green fluorescent protein reporter gene using Lipofectamine 2000. Green fluorescent protein expression was studied under a reverse fluorescence microscope and the results were analyzed with the ImageJ software. Effect of different quantities of plasmid DNA and different Lipofectamine 2000 volumes on cell transfection efficiency was evaluated.
          Results: The optimal volume of Lipofectamine and quantity of plasmid was 2 µl and 1µg, respectively, which showed 59% efficiency for the transfection of SW480 cells at 24 hours post-transfection.
          Conclusion: This study shows that Lipofectamine 2000 is an efficient reagent for the delivery of genes into SW480 cells. According to the results, the quantity of DNA per transfection and reagent concentrations are essential factors for a successful transfection.
          Keywords: Optimization; pEGFP-NI; Lipofectamine; SW480.
Full-Text [PDF 596 kb]   (1048 Downloads)    
Type of Study: Original Paper |
Received: 2018/05/30 | Accepted: 2018/05/30 | Published: 2018/05/30 | ePublished: 2018/05/30

1. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nature Reviews Genetics. 2003; 4(5): 346-58. [DOI:10.1038/nrg1066]
2. Tenenbaum L, Lehtonen E, Monahan PE. Evaluation of risks related to the use of adeno-associated virus-based vectors. Current gene therapy. 2003; 3(6): 545-65. [DOI:10.2174/1566523034578131]
3. Lundstrom K, Boulikas T. Viral and non-viral vectors in gene therapy: technology development and clinical trials. Technology in cancer research & treatment. 2003; 2(5): 471-85. [DOI:10.1177/153303460300200513]
4. Zhou X, Huang L. DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action. Biochimica et Biophysica Acta (BBA)-Biomembranes. 1994; 1189(2): 195-203. [DOI:10.1016/0005-2736(94)90066-3]
5. Nabel EG, Gordon D, Yang Z-Y, Xu L, San H, Plautz GE, et al. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Human gene therapy. 1992; 3(6): 649-56. [DOI:10.1089/hum.1992.3.6-649]
6. Yang JP, Huang L. Time-dependent maturation of cationic liposome-DNA complex for serum resistance. Gene therapy. 1998; 5(3): 380-7. [DOI:10.1038/sj.gt.3300596]
7. Schmidt-Wolf GD, Schmidt-Wolf IG. Non-viral and hybrid vectors in human gene therapy: an update. Trends in molecular medicine. 2003; 9(2): 67-72. [DOI:10.1016/S1471-4914(03)00005-4]
8. Kim TK, Eberwine JH. Mammalian cell transfection: the present and the future. Analytical and Bioanalytical Chemistry. 2010; 397: 3173-3178. [DOI:10.1007/s00216-010-3821-6]
9. Labat-Moleur F, Steffan AM, Brisson C, Perron H, Feugeas O, Furstenberger P, et al. An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene therapy. 1996; 3(11): 1010-1017.
10. Maurisse R, De Semir D, Emamekhoo H, Bedayat B, Abdolmohammadi A, Parsi H, et al. Comparative transfection of DNA into primary and transformed mammalian cells from different lineages. BMC Biotechnology. 2010; 10:1. doi: 10.1186/1472-6750-10-9. [DOI:10.1186/1472-6750-10-9]
11. Avci-Adali M, Behring A, Keller T, Krajewski S, Schlensak C, Wendel HP. Optimized conditions for successful transfection of human endothelial cells with in vitro synthesized and modified mRNA for induction of protein expression. Journal of biological engineering. 2014; 8(1): 8. doi: 10.1186/1754-1611-8-8. [DOI:10.1186/1754-1611-8-8]
12. Morrey ME, Anderson PA, Chambers G, Paul R. Optimizing nonviral-mediated transfection of human intervertebral disc chondrocytes. Spine J. 2008; 8(5): 796-803. [DOI:10.1016/j.spinee.2007.05.010]
13. Ward CM, Stern PL. The Human Cytomegalovirus Immediate‐Early Promoter is Transcriptionally Active in Undifferentiated Mouse Embryonic Stem Cells. Stem cells. 2002; 20(5): 472-5. [DOI:10.1634/stemcells.20-5-472]
14. Shabani M, Hemmati S, Hadavi R, Amirghofran Z, Jeddi-Tehrani M, Rabbani H, et al. Optimization of gene transfection in murine myeloma cell lines using different transfection reagents. Avicenna journal of medical biotechnology. 2010; 2(3): 123-30.
15. Salimzadeh L, Jaberipour M, Hosseini A, Ghaderi A. Non-viral transfection methods optimized for gene delivery to a lung cancer cell line. Avicenna journal of medical biotechnology. 2013; 5(2):68-77.
16. Hashemi A, Roohvand F, Ghahremani M, Aghasadeghi M, Vahabpour R, Motevali F, et al. Optimization of transfection methods for Huh-7 and Vero cells: A comparative study. Tsitol Genet. 2012; 46(6): 19-27. [DOI:10.3103/S0095452712060035]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2007 All Rights Reserved | Medical Laboratory Journal